shortagewatch

Home / Cancer and immune system / Erlotinib

ATC L01EB02 · Antineoplastic Agents

Erlotinib shortage

As of 31 Oct 2026, Erlotinib has a reported shortage in 2 of the 5 countries we track (Italy, Belgium), covering 3 products.

Countries2/5
Products3packs or presentations
Short since14 Feb 20224.7 years ago
Earliest return27 Nov 2026company estimate
No return date1products
Main reasonOther
GermanyNo reported shortageItaly1 pack shortSpainNo reported shortageAustriaNo reported shortageBelgium2 packs short

Timeline

ItalyBelgium
2023202420252026Tarceva 150 mg (Abacus Medicine) film-coat. Tarceva 150 mg (Abacus Medicine) film-coat. tabl. 30Erlotinib Sandoz 100 mg film-coat. tabl. 30Erlotinib Sandoz 100 mg film-coat. tabl. 30today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITERLOTINIB MYLAN announcedMYLAN S.P.A.1 Jan 2027not givenManufacturing problem
Problemi produttivi
BETarceva 150 mg (Abacus Medicine) film-coat. tabl. 30Roche Registration14 Feb 202226 May 2027Other
Other reason
BEErlotinib Sandoz 100 mg film-coat. tabl. 30Sandoz13 Oct 202627 Nov 2026Other
Other reason

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Gefitinib